Awareness, treatment and control of hypertension, dyslipidaemia and diabetes mellitus in an Iranian population: The IHHP study

Eastern Mediterranean Health Journal

Volumn 15, Issue 6, 2009, Pages 1455-1463

  Shirani, S ^a   Kelishadi, R ^b   Sarrafzadegan, N ^b   Khosravi, A ^a   Sadri, Gh ^a   Amani, A ^c   Heidari, S ^c   Ramezani, M A ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CITY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; IRAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE;

ADULT; AGED; ANALYSIS OF VARIANCE; ATTITUDE TO HEALTH; AWARENESS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DYSLIPIDEMIAS; EDUCATIONAL STATUS; FEMALE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; HYPERTENSION; IRAN; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; URBAN HEALTH;

EID: 75449110924     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Anderson RN. Deaths: leading causes for 2000: national vital statistics reports. Hyattsville, Maryland, National Center for Health Statistics, 2002:1-48.
2. Murray C JL, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet, 1997, 349:1436-42.
3. World Health Report 2002 - Reducing risks, promoting healthy life. Geneva, World Health Organization, 2002.
4. From the Centers for Disease Control and Prevention. State-specific trends in high blood cholesterol awareness among persons screened - United States, 1991-1999. Journal of the American Medical Association, 2001, 286:1706-7.
5. Lenfant C. Reflections on hypertension control rates: a message from the director of the National Heart, Lung, and Blood Institute. Archives of internal medicine, 2002, 162:131-2.
6. Sarrafzadegan N, Sajady F. Hypertension and diabetes situation in the Eastern Mediterranean Region with special reference to Iran. In: Dhalla NS et al., eds. Frontiers in cardiovascular health, 1st ed. Boston, Kluwer Academic Publishing, 2003:451-72.
7. Sarrafzadegan N et al. Isfahan Healthy Heart Programme: a comprehensive integrated community-based programme for cardiovascular disease prevention and control. Design, methods and initial experience. Acta cardiologica, 2003, 58:309-20.
8. Sixth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, National Institute of Health, 1997.
9. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association, 2001, 285:2486-97.
10. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic medicine, 1998, 15:539-49.
11. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes care, 1997, 20, 1183-97.
12. Sarrafzadegan N, Amininik S. Blood pressure pattern in urban and rural areas in Isfahan, Iran. Journal of human hypertension, 1997, 11:425-8.
13. Altun B et al. Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003. Journal of hypertension, 2005, 23:1817-23.
14. Bharucha NE, Kuruvilla T. Hypertension in the Parsi community of Bombay: a study on prevalence, awareness and compliance to treatment. BMC public health, 2003, 3:1.
15. Cifkova R et al. Trends in blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2000/01. Journal of hypertension, 2004, 22:1479-85.
16. Gus I et al. Prevalence, awareness, and control of systemic arterial hypertension in the state of Rio Grande do Sul. Arquivos brasileiros de cardiologia, 2004, 83:429-33.
17. Li W et al. Awareness, treatment and control of hypertension in patients attending hospital clinics in China. Journal of hypertension, 2003, 21:1191-7.
18. Marques-Vidal P et al. Sex differences in awareness and control of hypertension in France. Journal of hypertension, 1997, 15:1205-10.
19. Marques-Vidal P et al. Awareness and control of hypertension and hypercholesterolaemia in France and Northern Ireland. QJM, 1997, 90:341-5.
20. Rywik SL et al. Poland and U.S. collaborative study on cardiovascular epidemiology hypertension in the community: prevalence, awareness, treatment, and control of hypertension in the Pol-MONICA Project and the U.S. Atherosclerosis Risk in Communities Study. Annals of epidemiology, 1998, 8:3-13.
21. Stergiou GS et al. Prevalence, awareness, treatment, and control of hypertension in Greece: the Didima study. American journal of hypertension, 1999, 12:959-65.
22. Gu D et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension, 2002, 40:920-7.
23. Ibrahim MM et al. Hypertension prevalence, awareness, treatment, and control in Egypt. Results from the Egyptian National Hypertension Project (NHP). NHP Investigative Team. Hypertension, 1995, 26:886-90.
24. Macedo ME et al. Prevalence, awareness, treatment and control of hypertension in Portugal: the PAP study. Journal of hypertension, 2005, 23:1661-6.
25. Muntner P et al. Factors associated with hypertension awareness, treatment, and control in a representative sample of the Chinese population. Hypertension, 2004, 43:578-85.
26. Wang Z et al. Trends in prevalence, awareness, treatment and control of hypertension in the middle-aged population of China, 1992-1998. Hypertension research, 2004, 27:703-9.
27. Lim TO, Morad Z. Prevalence, awareness, treatment and control of hypertension in the Malaysian adult population: results from the national health and morbidity survey 1996. Singapore medical journal, 2004, 45:20-7.
28. Jo I et al. Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: the Ansan study. Journal of hypertension, 2001, 19:1523-32.
29. Smith WC et al. Control of blood pressure in Scotland: the rule of halves. British medical journal, 1990, 300:981-3.
30. De Souza LJ, Souto Filho JTD, De Souza TF. Prevalence of dyslipidemia and risk factors in Campos dos Goytacazes, in the Brazilian State of Rio de Janeiro. Arquivos brasileiros de cardiologia, 2003, 81:257-64.
31. He J, Gu D, Reynolds K. Serum Total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation, 2004, 110:405-11.
32. Frontini MG et al. Awareness of hypertension and dyslipidemia in a semirural population of young adults: the Bogalusa Heart Study. Preventive medicine, 2003, 36:398-402.
33. Ford ES et al. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: Findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation, 2003, 107:2185-9.
34. Delavari A et al. [National program of prevention and control of diabetes mellitus, 2nd ed.]. Tehran, Ministry of Health and Medical Education, 2004 [In Farsi].
35. Yusuf S et al. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation, 2001, 104(23):2855-64.
36. Abazar P, Amini P, Amini M. [Management of diabetic patients in Isfahan]. Research in medical sciences, 2001, 2:102-5 [In Farsi].
37. Amini M, Aminoroaya A., Rezvanian H. [Glycemic control in diabetic patients in Isfahan]. Research in medical sciences, 1997, 2:8-12 [In Farsi].